Category:Satyanarayana Kuchimanchi of Acton MA (US)

Satyanarayana Kuchimanchi of Acton MA (US)

Executive Summary

Satyanarayana Kuchimanchi of Acton MA (US) is an inventor who has filed 2 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (2 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (2 patents), Spatial arrangement of the modifications (2 patents), and they have worked with companies such as Alnylam Pharmaceuticals, Inc. (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

File:Satyanarayana Kuchimanchi of Acton MA (US) Monthly Patent Applications.png

Technology Areas

File:Satyanarayana Kuchimanchi of Acton MA (US) Top Technology Areas.png

List of Technology Areas

• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 2 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N2310/343 (Spatial arrangement of the modifications): 2 patents
• A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 1 patents
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
• C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2320/32 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2320/51 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61P1/16 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P1/18 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P3/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P3/06 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P3/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P9/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P9/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P13/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P15/08 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P43/00 (Drugs for specific purposes, not provided for in groups): 1 patents
• C12N2310/315 (of the backbone): 1 patents
• C12N2310/321 (2'-O-R Modification): 1 patents
• C12N2310/322 (2'-R Modification): 1 patents
• C12N2310/335 (of the base): 1 patents
• C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents

Companies

File:Satyanarayana Kuchimanchi of Acton MA (US) Top Companies.png

List of Companies

• Alnylam Pharmaceuticals, Inc.: 2 patents

Collaborators

• Gregory Hinkle of Plymouth MA (US) (2 collaborations)
• Martin A. Maier of Belmont MA (US) (2 collaborations)
• Stuart Milstein of Arlington MA (US) (2 collaborations)
• Donald Foster of Attleboro MA (US) (1 collaborations)
• Brian Bettencourt of Groton MA (US) (1 collaborations)
• Klaus Charisse of Acton MA (US) (1 collaborations)
• Kevin Fitzgerald of Brookline MA (US) (1 collaborations)
• William Querbes of Boston MA (US) (1 collaborations)
• James Butler of Lynnfield MA (US) (1 collaborations)
• Stephanie Williams of Littleton MA (US) (1 collaborations)
• Abigail Liebow of Somerville MA (US) (1 collaborations)
• Muthiah Manoharan of Weston MA (US) (1 collaborations)